Adaptin Bio, Inc. (APTN) Operating income 2023–2025
Adaptin Bio, Inc. (APTN) annual operating income history from SEC filings — each fiscal year as reported.
-$5.4MFY2025 · since FY2023: -$85,593 → -$5.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$5.4M | -110.7% |
| FY2024 | -$2.6M | -2902.4% |
| FY2023 | -$85,593 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More APTN financial trends
APTN RevenueAPTN Net incomeAPTN Net marginAPTN Gross profitAPTN Gross marginAPTN Operating marginAPTN Operating cash flowAPTN Free cash flowAPTN Capital expendituresAPTN Return on equityAPTN Stock buybacksAPTN Dividends paidAPTN Total assetsAPTN Total liabilitiesAPTN Shareholders’ equityAPTN overview →